In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 7, 2000, Pages 831-838

  Balan, Guhan ^a,b   Timmins, Peter ^a   Greene, Douglas S ^a   Marathe, Punit H ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b 206 Carnegie Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; METFORMIN;

ARTICLE; DRUG ABSORPTION; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; NORMAL HUMAN; TABLET FORMULATION;

EID: 0033912439     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774688     Document Type: Article

References (16)

1. Amidon, G. L., Lennernas, H., Shah, V. P., Crison, J. R. (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm. Res. 12: 413-420
2. Blume, H., Ali, S. L., Siewert, M. (1993) Pharmaceutical quality of glibenclamide products. A multinational post-market comparative study. Drug Dev. Ind. Pharm. 19: 2713-2741
3. Brockmeier, D., Grigokit, H., Leonhardt, H. (1984) In vitro-in vivo correlation, a time scaling problem? Arzneim. Forsch. 34: 1604-1607
4. Brockmeier, D. (1985) Absorption of glibenclamide from different sites of the gastrointestinal tract. Eur. J. Clin. Pharmacol. 29: 193-197
5. Hermann, L. S., Schersten, B., Melander, A. (1994) Anti-hyperglycemic efficacy, response prediction, and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination. Diabet. Med. 11: 953-960
6. Ikegami, H., Shima, K., Tanaka, A., Tahara, Y., Hirota, M., Kumahara, Y. (1985) Pharmacokinetics of glibenclamide: heterogeneity in its absorption. Med. J. Osaka Univ. 35: 55-61
7. Lehto, P., Laine, K., Kivisto, K. T., Neuvonen, P. J. (1996) The effect of pH on the in-vitro dissolution of three second generation sulphonylurea preparations: mechanism of antacid-sulphonylurea interaction. J. Pharm. Pharmacol. 48: 899-901
8. Levy, G. (1964) Effect of dosage form on drug absorption, a frequent variable in clinical pharmacology. Arch. Int. Pharmacodyn. 52: 59-68
9. Levy, G., Hollister, L. E. (1965) Dissolution rate limited absorption in man: factors influencing drug absorption from prolonged-release dosage form. J. Pharm. Sci. 54: 1121-1125
10. Mojaverian, P., Radwanski, E., Lin, C. C., Cho, P., Vadino, W. A., Rosen, J. M. (1992) Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations. Pharm. Res. 9: 450-456
11. Mojaverian, P., Rosen, J., Vadino, W. A., Liebowitz, S., Radwanski, E. (1997) In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate. J. Pharm. Biomed. Analysis 15: 439-445
12. Negebauer, G., Betzien, G., Hrstka, V., Kaufmann, B., von Mollendorff, E., Abshagen, U. (1985) Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N). Int. J. Clin. Pharmacol. Ther. Toxicol. 23: 453-460
13. Pearson, J. G. (1985) Pharmacokinetics of glyburide. Am J. Med. 79 (Suppl. 3B): 67-71
14. Rogers, H. J., Spector, R. G., Morrison, P. J., Bradbrook, I. D. (1982) Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid Chromatographic assay. Diabetalogia 23: 37-40
15. U.S. FDA Guidance for Industry (1997) Extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
16. van Bommel, E. M. G., Ragheobar, M., Tukker, J. J. (1991) Comparison of in-vitro and in-vivo release characteristics of acetaminophen from gradient matrix systems. Biopharm. Drug Disp. 12: 367-373